Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,852
datasets available to search
ShareScore release 0.7.1
Dataset results
2,852 results for “Hepatocellular carcinoma”
Identification of an Immune Single Cell Transcriptomic Profile of Responder and Non-responder Hepatocellular Carcinoma Patients Treated With Immune-checkpoint Inhibitors
ClinicalTrials.gov study NCT07273708. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT01203787. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01639352. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm
ClinicalTrials.gov study NCT00479050. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02527772. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02834780. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01020812. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on the Efficacy and Safety of Transarterial Chemoembolization Combined with Targeted Immunotherapy in Patients with Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06715072. IPD Sharing: NO. Countries: 0. Publications: 1.
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
ClinicalTrials.gov study NCT03785210. IPD Sharing: YES. Countries: 1. Publications: 0.
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00503867. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06143579. IPD Sharing: NO. Countries: 0. Publications: 8.
[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03648073. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gut Microbiota in People With Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT02599909. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)
ClinicalTrials.gov study NCT06928415. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT04541173. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02279719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03781960. IPD Sharing: NO. Countries: 1. Publications: 0.
Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT02898415. IPD Sharing: NO. Countries: 0. Publications: 1.
Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00844883. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib
ClinicalTrials.gov study NCT03163992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.